...
首页> 外文期刊>International Journal of Pharmaceutical Sciences and Research >METHOD DEVELOPMENT AND VALIDATION OF STABILITY INDICATING METHOD FOR ANALYSIS OF LOSARTAN POTASSIUM IN BULK DRUG AND DOSAGE FORM FORMULATION
【24h】

METHOD DEVELOPMENT AND VALIDATION OF STABILITY INDICATING METHOD FOR ANALYSIS OF LOSARTAN POTASSIUM IN BULK DRUG AND DOSAGE FORM FORMULATION

机译:散装药中洛沙坦钾的稳定性指示方法的方法开发与验证及剂型配制。

获取原文

摘要

Losartan potassium in tablet dosage form, separation achieved with C 18 column (Kromasil 100-5C18250mm x4.6mm E82860 i.d., 5μm particle), ambient temperature with isocratic mode with mobile phase containing 40:60 Acetonitrile: Buffer consist of 10.5mM of disodium hydrogen phosphate and 10mM potassium dihydrogen phosphate, pH 3.5 adjusted by 10 % Orthophosphoric acid and at flow rate 1.0ml/minute the eluent was monitored at 250nm. The selected chromatographic conditions were found to be effectively separate Losartan potassium 9.98min. The proposed method was found to be linear over the range of 6.4-9.6μg/ml. The drug was subjected to oxidation, acid, alkaline, photolysis and heat stress conditions for degradation. The method was validated for specificity, linearity, accuracy, robustness and solution stability
机译:氯沙坦钾片状剂型,使用C 18色谱柱(Kromasil 100-5C18250mm x4.6mm E82860 id,5μm颗粒),等温模式下环境温度,流动相含40:60乙腈:缓冲液由10.5mM氢二钠组成用10%的正磷酸调节pH值为3.5的磷酸酯和10mM磷酸二氢钾,流速为1.0ml / min,在250nm处监测洗脱液。发现所选的色谱条件有效分离了氯沙坦钾9.98min。发现该方法在6.4-9.6μg/ ml范围内是线性的。使药物经受氧化,酸,碱,光解和热应激条件降解。验证了该方法的特异性,线性,准确性,鲁棒性和溶液稳定性

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号